Neutrophil autophagy during human active tuberculosis is modulated by SLAMF1

• Published in: Autophagy 2021-09, Vol.17 (9), p.2629-2638
• Main Authors: Pellegrini, Joaquín Miguel, Sabbione, Florencia, Morelli, María Paula, Tateosian, Nancy Liliana, Castello, Florencia Andrea, Amiano, Nicolás Oscar, Palmero, Domingo, Levi, Alberto, Ciallella, Lorena, Colombo, María Isabel, Trevani, Analía Silvina, García, Verónica Edith
• Format: Article
• Language: English
• Subjects: Autophagy; Humans; immune response; Letter To The Editor; Macrophages - metabolism; Mycobacterium tuberculosis; neutrophil; Neutrophils - cytology; Neutrophils - microbiology; patients; Signaling Lymphocytic Activation Molecule Family Member 1 - metabolism; SLAMF1; tuberculosis; Tuberculosis - microbiology
• ISSN: 1554-8627; 1554-8635
• DOI: 10.1080/15548627.2020.1825273

Neutrophils infected with Mycobacterium tuberculosis (Mtb) predominate in tuberculosis patients' lungs. Neutrophils phagocytose the pathogen, but the mechanism of pathogen elimination is controversial. Macroautophagy/autophagy, a crucial mechanism for several neutrophil functions, can be modulated by immunological mediators. The costimulatory molecule SLAMF1 can act as a microbial sensor in macrophages being also able to interact with autophagy-related proteins. Here, we demonstrate for the first time that human neutrophils express SLAMF1 upon Mtb-stimulation. Furthermore, SLAMF1 was found colocalizing with LC3B + vesicles, and activation of SLAMF1 increased neutrophil autophagy induced by Mtb. Finally, tuberculosis patients' neutrophils displayed reduced levels of SLAMF1 and lower levels of autophagy against Mtb as compared to healthy controls. Altogether, these results indicate that SLAMF1 participates in neutrophil autophagy during active tuberculosis. Abbreviations: AFB: acid-fast bacilli; BafA1: bafilomycin A 1 ; CLL: chronic lymphocytic leukemia; DPI: diphenyleneiodonium; EVs: extracellular vesicles; FBS: fetal bovine serum; HD: healthy donors; HR: high responder (tuberculosis patient); IFNG: interferon gamma; IL1B: interleukin 1 beta; IL17A: interleukin 17A; IL8: interleukin 8; LR: low responder (tuberculosis patient); mAb: monoclonal antibody; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK: mitogen-activated protein kinase; MAPK1/ERK2: mitogen-activated protein kinase 1; MAPK14/p38: mitogen-activated protein kinase 14; Mtb: Mycobacterium tuberculosis; Mtb-Ag: Mycobacterium tuberculosis, Strain H37Rv, whole cell lysate; NETs: neutrophils extracellular traps; PPD: purified protein derivative; ROS: reactive oxygen species; PIK3C3/VPS34: phosphatidylinositol 3-kinase catalytic subunit type 3; SLAMF1: signaling lymphocytic activation molecule family member 1; TB: tuberculosis; TLR: toll like receptor